NewsMay 10
Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective June 30, July 1, 2024
Please be advised of the changes in the following Corporate Officers at PHC Holdings Corporation effective on June 30, July 1, 2024.
(1) Resignation of Corporate Officers on June 30, 2024
| Position/Title |
Name |
Remarks |
Executive Corporate Officer
Chief Financial Officer (CFO) |
Frederick Reidenbach |
Corporate Accounting, Corporate Finance,
Information Technology |
(2) Change in Responsibilities of Corporate Officers on July 1, 2024
| Name |
New Responsibility from July 1, 2024 |
Responsibility Until June 30, 2024 |
| Koichiro Sato |
Senior Executive Vice President, Representative Director
Chief Operating Officer（COO）
Chief Strategy Officer（CSO） |
Senior Executive Vice President, Representative Director
Chief Operating Officer（COO） |
| Ryuichi Hirashima |
Senior Executive Corporate Officer
Chief Administrative Officer（CAO）
Chief Human Resources Officer（CHRO）
Chief Transformation Officer（CTO）
Legal & Compliance, Intellectual Property
Information Technology |
Senior Executive Corporate Officer
Chief Administrative Officer（CAO）
Chief Human Resources Officer（CHRO）
Chief Transformation Officer（CTO）
Legal & Compliance, Intellectual Property |
| Kaiju Yamaguchi |
Executive Corporate Officer
Chief Financial Officer（CFO）
Investor Relations, Corporate Communications |
Executive Corporate Officer
Chief Strategy Officer（CSO） |
(3) Corporate Officers at PHC Holdings Corporation on July 1, 2024
| Position/Title |
Name |
Role and Responsibilities |
| Chief Executive Officer (CEO) |
Kyoko Deguchi |
Group Management, Internal Audit |
Chief Operating Officer (COO)
Chief Strategy Officer（CSO） |
Koichiro Sato |
Technology, Manufacturing, Procurement, Risk Management
Corporate Planning, Business Development, Medical Policy & Public Affairs
Head of Diabetes Management Domain,
Head of Healthcare Solutions Domain |
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO) |
Ryuichi Hirashima |
General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation, Information Technology |
Executive Corporate Officer
Chief Financial Officer (CFO) |
Kaiju Yamaguchi |
Corporate Accounting, Corporate Finance,
Investor Relations, Corporate Communications |
| Executive Corporate Officer |
Nobuaki Nakamura |
Head of Diagnostics & Life Sciences Domain
President, Representative Director, PHC Corporation |
| Corporate Officer |
Robert Schumm |
Head of BGM Business
President, Ascensia Diabetes Care Holdings AG |
| Corporate Officer |
Steven Lynum |
Deputy Head of Diagnostics & Life Sciences Domain
Head of Pathology Business
President, Epredia Holdings Ltd. |
| Corporate Officer |
Kenichi Uchino |
Head of LSIM Business
President and Chief Executive Officer, LSI Medience Corporation |
| Corporate Officer |
Chikara Takauo |
Head of Biomedical Business
Director, PHC Corporation |
| Corporate Officer |
Hideaki Takahashi |
Head of Healthcare IT Solution Business
President, Representative Director, Wemex Corporation |